亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis

安慰剂 医学 溃疡性结肠炎 内科学 临床试验 荟萃分析 置信区间 随机对照试验 科克伦图书馆 外科 病理 疾病 替代医学
作者
Rocío Sedaño,Malcolm Hogan,Tran M Nguyen,Joshua Chang,Guangyong Zou,John K MacDonald,Niels Vande Casteele,Jurij Hanžel,Eileen Crowley,Robert J. Battat,Parambir Singh Dulai,Siddharth Singh,Geert D’Haens,William J. Sandborn,Brian G. Feagan,Christopher Ma,Vipul Jairath
出处
期刊:Journal of Crohn's and Colitis [Oxford University Press]
卷期号:16 (2): 224-243 被引量:26
标识
DOI:10.1093/ecco-jcc/jjab135
摘要

BACKGROUND AND AIMS: Quantifying placebo rates and the factors influencing them are essential to inform trial design. We provide a contemporary summary of clinical, endoscopic, histological and safety placebo rates in induction and maintenance clinical trials of ulcerative colitis, and identify factors influencing them. METHODS: MEDLINE, EMBASE and the Cochrane library were searched from April 2014 to April 2020, updating a prior meta-analysis that searched from inception to April 2014. We included placebo-controlled trials of aminosalicylates, corticosteroids, immunosuppressives, small-molecules and biologics in adults with ulcerative colitis. Placebo rates were pooled using random-effects and mixed-effects meta-regression models to assess the associated study-level. RESULTS: In 119 trials [92 induction, 27 maintenance] clinical, endoscopic and histological remission placebo rates for induction trials were 11% (95% confidence interval [CI] 9-13%), 19% [95% CI 15-23%] and 15% [95% CI 11-19%], respectively; for maintenance trials, clinical and endoscopic placebo remission rates were 18% [95% CI 12-25%] and 20% [95% CI 15-25%], respectively. Higher endoscopic subscore and a higher rate of exposure to prior biologic therapy at enrolment were associated with lower clinical and endoscopic placebo remission rates. Absence of central reading was associated with an increase in placebo endoscopic response and remission rates. More follow-up visits and increasing trial duration were associated with higher clinical placebo rates. CONCLUSIONS: Placebo rates in ulcerative colitis trials vary according to the endpoint assessed, whether it is for assessment of response or remission, and whether the trial is designed for induction or maintenance. These contemporary rates across different endpoints and drug classes will help to inform trial design.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
祎辰完成签到 ,获得积分10
4秒前
现代的如容完成签到,获得积分10
8秒前
lyp完成签到 ,获得积分10
12秒前
13秒前
平和的狍子完成签到 ,获得积分10
15秒前
汉堡包的应助被breeze采纳,获得10
18秒前
Akim的应助被Yuantian采纳,获得30
19秒前
20秒前
乐正亦寒完成签到 ,获得积分10
26秒前
酷炫鹏煊完成签到 ,获得积分10
28秒前
学霸宇大王完成签到 ,获得积分10
33秒前
淡然葶完成签到 ,获得积分10
33秒前
黑早早完成签到,获得积分10
33秒前
谦让的沛芹完成签到,获得积分10
35秒前
36秒前
37秒前
38秒前
41秒前
48秒前
49秒前
liugm发布了新的文献求助10
50秒前
toxin37完成签到 ,获得积分10
52秒前
小井盖完成签到 ,获得积分0
53秒前
54秒前
含蓄的芝麻完成签到,获得积分10
55秒前
陌陌完成签到 ,获得积分10
56秒前
菌菌的应助被郦稀采纳,获得30
59秒前
1分钟前
煊陌完成签到 ,获得积分10
1分钟前
xiaoyin完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
Lifel完成签到,获得积分10
1分钟前
1分钟前
1分钟前
A水暖五金批发张哥完成签到,获得积分10
1分钟前
Ni完成签到 ,获得积分10
1分钟前
云墨完成签到 ,获得积分10
1分钟前
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8158598
求助须知:如何正确求助?哪些是违规求助? 9554358
关于积分的说明 21719087
捐赠科研通 7748128
什么是DOI,文献DOI怎么找? 3427032
关于科研通互助平台的介绍 2551902
邀请新用户注册赠送积分活动 2471277